Dallah gets CMA nod on capital hike to buy AYYAN’s holdings in Al-Ahsa, Al-Salam

Logos of Dallah Healthcare Co. and AYYAN Investment Co. 

The Capital Market Authority (CMA) approved Dallah Healthcare Co.’s request to increase its capital from SAR 976.81 million to SAR 1.02 billion, the market regulator said in a statement today, Feb. 5.

The planned capital top-up will be made through the issuance of 3.89 million ordinary shares to acquire a 97.41% stake in Al-Ahsa Medical Services Co. and 100% of Al-Salam Medical Services Co., both owned by AYYAN Investment Co.

The shareholders’ circular related Dallah’s proposed capital hike will be published within sufficient time before the deciding extraordinary general meeting (EGM), the CMA added.

The shareholders’ circular must include all relevant information that shareholders need to know before making an informed decision when voting on the capital increase for the purpose described, including the rise in capital and the associated risk factors.

For More Mergers and Acquisitions

A voting decision without reading the shareholders’ circular and carefully reviewing its content may involve high risks. Therefore, shareholders should carefully read the provided documents to confidently reach an informed decision. If the shareholders’ circular proves difficult to understand, it is recommended to consult with an authorized financial advisor, the authority noted.

The CMA's approval of Dallah’s planned capital hike should not be considered as an endorsement of the aforementioned pursuit. It merely means that the legal requirements as per the Capital Market Law and its Implementing Regulations have been met.